Newsletter
Home Infectious Diseases

Infectious Diseases

Lenacapavir Shows Efficacy in Treating Multidrug Resistant HIV-1 Infection
Biotech

Lenacapavir Shows Efficacy in Treating Multidrug Resistant HIV-1 Infection

ImmunoFrontiers Team -
0
BTK Inhibitor Acalabrutinib Supports Patients with Severe Cases of COVID-19
Cutting Edge Therapies

BTK Inhibitor Acalabrutinib Supports Patients with Severe Cases of COVID-19

ImmunoFrontiers Team -
0
Altimmune To Initiate Phase 1/2 Clinical Trial of COVID-19 Therapy T-COVID
Biotech

Altimmune To Initiate Phase 1/2 Clinical Trial of COVID-19 Therapy T-COVID

ImmunoFrontiers Team -
0
Novavax Expands Manufacturing Capacity by Acquiring Praha Vaccines
Biotech

Novavax Expands Manufacturing Capacity by Acquiring Praha Vaccines

ImmunoFrontiers Team -
0
ARCA Biopharma to Develop Tissue Factor Inhibitor as COVID-19 Therapy
Biotech

ARCA Biopharma to Develop Tissue Factor Inhibitor as COVID-19 Therapy

ImmunoFrontiers Team -
0
Heat Biologics Partners with Waisman to Manufacture COVID-19 Vaccine
Biotech

Heat Biologics Partners with Waisman to Manufacture COVID-19 Vaccine

ImmunoFrontiers Team -
0
Novavax COVID-19 Vaccine Advances to Phase 1/2 Human Trials
Biotech

Novavax COVID-19 Vaccine Advances to Phase 1/2 Human Trials

ImmunoFrontiers Team -
0
NantKWest & Be The Match to Advance COVID-19 Therapy BM-AlloMSC
Biotech

NantKWest & Be The Match to Advance COVID-19 Therapy BM-AlloMSC

ImmunoFrontiers Team -
0
AstraZeneca to Develop COVID-19 Vaccine with Oxford University
Biotech

AstraZeneca to Develop COVID-19 Vaccine with Oxford University

ImmunoFrontiers Team -
0
Vaxart Selects Lead COVID-19 Vaccine Candidate, KindredBio a Partner
Biotech

Vaxart Selects Lead COVID-19 Vaccine Candidate, KindredBio a Partner

ImmunoFrontiers Team -
0
123...5Page 1 of 5

Contact

Connect

Follow Us

ImmunoFrontiers © 2019-2021. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.

error: Content is protected.